Literature DB >> 8298236

Left ventricular diastolic function of the reperfused postischemic donor heart.

T Shirai1, M Sunamori, A Suzuki.   

Abstract

This study examined the pathophysiological relationship between left ventricular diastolic function and myocardial biochemical changes during reperfusion following hypothermic cardioplegic preservation of the donor heart. Isolated canine hearts (n = 47) were preserved for 6 h at 5 degrees C, followed by normothermic reperfusion for 2 h. Regression analysis demonstrated a highly significant correlation between: Left ventricular maximum -dp/dt and the left ventricular end-diastolic pressure (r = -0.56, P = 0.001); myocardial concentrations of adenosine triphosphate (ATP) and Ca2+ (r = -0.59, P = 0.0001); maximum -dp/dt and myocardial concentrations of: (1) ATP, (2) Ca2+, and (3) total adenine nucleotide with left ventricular volume loading (r = -0.53, P = 0.003; r = 0.51, P = 0.002; and r = 0.52, P = 0.002, respectively); and left ventricular end-diastolic pressure and myocardial Ca2+ (r = 0.66, P = 0.0001). These results suggest that left ventricular relaxation, as assessed by maximum -dp/dt, has a negative correlation with left ventricular stiffness, as determined by the end-diastolic pressure in preserved donor hearts. Furthermore, increased myocardial Ca2+ concentrations reflect exhaustion of myocardial ATP. Thus, the myocardial Ca2+ concentration correlates directly with wall stiffness and inversely with ventricular relaxation, while ATP concentration correlates directly with ventricular relaxation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298236     DOI: 10.1007/BF00311370

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  31 in total

1.  Factors which affect the diastolic pressure-volume curve.

Authors:  S A Glantz; W W Parmley
Journal:  Circ Res       Date:  1978-02       Impact factor: 17.367

2.  Differential extractability of creatine phosphate and ATP from cardiac muscle with ethanol and perchloric acid solution.

Authors:  M Bessho; F Ohsuzu; S Yanagida; N Sakata; N Aosaki; T Tajima; H Nakamura
Journal:  Anal Biochem       Date:  1991-01       Impact factor: 3.365

Review 3.  Reperfusion injury and its pharmacologic modification.

Authors:  L H Opie
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

4.  Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids.

Authors:  A L Steiner; A S Pagliara; L R Chase; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

5.  Metabolic and functional effects of progressive degrees of hypothermia during global ischemia.

Authors:  J T Flaherty; H V Schaff; R A Goldman; V L Gott
Journal:  Am J Physiol       Date:  1979-06

6.  Myocardial cation contents during induction of calcium paradox.

Authors:  L E Alto; N S Dhalla
Journal:  Am J Physiol       Date:  1979-12

7.  Immunochemiluminometric assay of creatine kinase MB with a monoclonal antibody to the MB isoenzyme.

Authors:  U Piran; D W Kohn; L S Uretsky; D Bernier; E H Barlow; C A Niswander; M Stastny
Journal:  Clin Chem       Date:  1987-09       Impact factor: 8.327

8.  Hypoxia-reoxygenation induced increase in cellular Ca2+ in myocytes and perfused hearts: the role of mitochondria.

Authors:  D Stone; V Darley-Usmar; D R Smith; V O'Leary
Journal:  J Mol Cell Cardiol       Date:  1989-10       Impact factor: 5.000

9.  Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange.

Authors:  M Tani; J R Neely
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

10.  Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart.

Authors:  C Steenbergen; E Murphy; J A Watts; R E London
Journal:  Circ Res       Date:  1990-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.